← Open Payments lookup

KAYLA AMRHEIN: Open Payments

NPI 1730727678 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,589 in 70 payments from 15 companies in 2025. Trend: 2023 $2,208 · 2024 $3,310 · 2025 $1,589

Food & beverage: $1,589
CompanyPaymentsAmount
ABBVIE INC.26$575
Takeda Pharmaceuticals U.S.A., Inc.7$189
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$157
Janssen Biotech, Inc.8$135
GENZYME CORPORATION3$86
Aimmune Therapeutics, Inc.3$76
Phathom Pharmaceuticals, Inc.3$75
Janssen Scientific Affairs, LLC1$69
Madrigal Pharmaceuticals2$52
Gilead Sciences, Inc.2$42

Products named: CREON, TREMFYA, SKYRIZI, XIFAXAN, ENTYVIO, RINVOQ, DUPIXENT, ZENPEP.

Industry payments across MD — which companies pay providers there.